US Patent 10683503 Antisense oligomers for treatment of conditions and diseases
Patent 10683503 was granted and assigned to Stoke Therapeutics on June, 2020 by the United States Patent and Trademark Office.
All edits
Edits on 19 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 Apr, 2023
Golden AI
Infobox
Patent Citations Received
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
106835030
Date of Patent
June 16, 2020
0Patent Application Number
165619600
Date Filed
September 5, 2019
0Official Website
Patent Citations
Patent Citations Received
Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Edits on 26 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
106835030
Date of Patent
June 16, 2020
0Patent Application Number
165619600
Date Filed
September 5, 2019
0Official Website
Patent Citations
Patent Citations Received
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 10 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 4 Feb, 2022
Golden AI
Edits made to:
Infobox (+10 properties)
US Patent 10683503 Antisense oligomers for treatment of conditions and diseases
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10683503
Date of patent
June 16, 2020
Patent application number
16561960
Date Filed
September 5, 2019
Patent citations
Patent primary examiner
Find more entities like US Patent 10683503 Antisense oligomers for treatment of conditions and diseases
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.